Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiake Xu

Showing results (221-230 of 401) with videos related to

Pageof 41
Sort By:
Journal of Cellular Physiology|April 15, 2009
Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascadesEstabelle Ang, Nathan J Pavlos, Sarah L Rea, et al.
International Journal of Molecular Sciences|January 21, 2017
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFATGuoju Hong, Lin Zhou, Xuguang Shi, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Materials Today. Bio|February 1, 2024
Cadherin-responsive hydrogel combined with dental pulp stem cells and fibroblast growth factor 21 promotes diabetic scald repair via regulating epithelial-mesenchymal transition and necroptosisWenjie Lu, Juan Zhao, Xiong Cai, et al.
Current Drug Targets|March 23, 2017
Therapeutic Potential and Outlook of Alternative Medicine for OsteoporosisTao Wang, Qian Liu, William Tjhioe, et al.
Frontiers in Pharmacology|August 1, 2020
Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 PathwaysJiyong Wei, Yicheng Li, Qian Liu, et al.
Journal of Advanced Research|July 31, 2025
Immunometabolism of macrophages in the bone microenvironment: a new perspective for bone healing therapyChenyu Wang, Qihang Wu, Luyao Zhuang, et al.
Cellular Signalling|March 31, 2025
Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1αLuqiong Cai, Chenxin Yu, Binli Zhao, et al.
Phytotherapy Research : PTR|February 15, 2024
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone lossYansi Xian, Yijie Gao, Yiji Su, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 13, 2022
Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8<sup>+</sup> T cells in osteosarcomaTianyu Xie, Wenyu Feng, Mingwei He, et al.
Pageof 41

Showing results (221-230 of 401) with videos related to

Sort By:
Pageof 41
Journal of Cellular Physiology|April 15, 2009
Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascadesEstabelle Ang, Nathan J Pavlos, Sarah L Rea, et al.
International Journal of Molecular Sciences|January 21, 2017
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFATGuoju Hong, Lin Zhou, Xuguang Shi, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Materials Today. Bio|February 1, 2024
Cadherin-responsive hydrogel combined with dental pulp stem cells and fibroblast growth factor 21 promotes diabetic scald repair via regulating epithelial-mesenchymal transition and necroptosisWenjie Lu, Juan Zhao, Xiong Cai, et al.
Current Drug Targets|March 23, 2017
Therapeutic Potential and Outlook of Alternative Medicine for OsteoporosisTao Wang, Qian Liu, William Tjhioe, et al.
Frontiers in Pharmacology|August 1, 2020
Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 PathwaysJiyong Wei, Yicheng Li, Qian Liu, et al.
Journal of Advanced Research|July 31, 2025
Immunometabolism of macrophages in the bone microenvironment: a new perspective for bone healing therapyChenyu Wang, Qihang Wu, Luyao Zhuang, et al.
Cellular Signalling|March 31, 2025
Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1αLuqiong Cai, Chenxin Yu, Binli Zhao, et al.
Phytotherapy Research : PTR|February 15, 2024
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone lossYansi Xian, Yijie Gao, Yiji Su, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 13, 2022
Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8<sup>+</sup> T cells in osteosarcomaTianyu Xie, Wenyu Feng, Mingwei He, et al.
Pageof 41